xAnts

xAnts

en-NZ

Nexalin technology's chief medical officer buys $7,700 in stock

2025-01-24MSN
Nexalin technology's chief medical officer buys $7,700 in stock

Officer of Nexalin Technology , Inc. (NASDAQ:NXL), has reported the purchase of common stock valued at a total of $7,700. The timing is notable as the stock has experienced significant volatility, dropping nearly 18% in the past week despite an impre ...Read more

Recommendations